Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices

Objectives: The aim of this study was to identify, compare and evaluate regulatory requirements for the biosimilar development and review processes in BRICS-TM (Brazil, Russia, India, China, South Africa, Turkey, Mexico) countries with mature regulatory systems of Australia, Canada, Singapore and Sw...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahalkar, Hasumati, Sheppard, Alan, Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381275/
https://www.ncbi.nlm.nih.gov/pubmed/34434109
http://dx.doi.org/10.3389/fphar.2021.711361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381275/
https://www.ncbi.nlm.nih.gov/pubmed/34434109
http://dx.doi.org/10.3389/fphar.2021.711361

Ejemplares similares